(EYE) National Vision Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63845R1077
EYE: Eyeglasses, Contact Lenses, Eye Exams, Optical Accessories
National Vision Holdings Inc., trading under the ticker EYE on NASDAQ, is a leading optical retailer in the United States. Founded in 1990 and headquartered in Duluth, Georgia, the company operates through two main segments: Owned & Host and Legacy. Its portfolio includes well-known brands such as Americas Best, Eyeglass World, and Vista Optical, offering a range of eyewear products, contact lenses, and optical accessories.
The companys business model is designed to cater to cost-conscious consumers, providing affordable eye exams and optical products. This approach has allowed National Vision to establish a strong presence in the value segment of the optical retail market. Additionally, the company has expanded into military bases, further diversifying its customer base and revenue streams.
From a financial perspective, National Vision Holdings has a market capitalization of approximately $978.86 million. The stocks forward P/E ratio is 21.14, indicating expectations of growth. The price-to-book ratio is 1.17, and the price-to-sales ratio is 0.45, suggesting that the company is reasonably valued relative to its assets and revenue.
Investors should consider the companys ability to maintain its competitive position in a rapidly evolving retail landscape. The optical industry is highly competitive, with both online and offline players vying for market share. National Visions focus on affordability and its extensive network of stores are key strengths. However, factors such as changing consumer preferences, supply chain disruptions, and regulatory changes could impact performance.
Overall, National Vision Holdings Inc. presents an interesting opportunity for investors seeking exposure to the optical retail sector, particularly those who believe in the continued demand for affordable eye care and eyewear. The companys track record, combined with its strategic initiatives, makes it a worth-watching stock in the specialty retail space.
Additional Sources for EYE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EYE Stock Overview
Market Cap in USD | 958m |
Sector | Consumer Cyclical |
Industry | Specialty Retail |
GiC Sub-Industry | Other Specialty Retail |
IPO / Inception | 2017-10-26 |
EYE Stock Ratings
Growth 5y | -63.0% |
Fundamental | -35.0% |
Dividend | 0.0% |
Rel. Strength Industry | -54 |
Analysts | 3.64/5 |
Fair Price Momentum | 9.72 USD |
Fair Price DCF | 11.19 USD |
EYE Dividends
No Dividends PaidEYE Growth Ratios
Growth Correlation 3m | 63.9% |
Growth Correlation 12m | -64% |
Growth Correlation 5y | -75% |
CAGR 5y | -12.52% |
CAGR/Max DD 5y | -0.15 |
Sharpe Ratio 12m | -2.06 |
Alpha | -57.51 |
Beta | 0.73 |
Volatility | 44.32% |
Current Volume | 1827.4k |
Average Volume 20d | 1624.8k |
As of March 14, 2025, the stock is trading at USD 11.91 with a total of 1,827,377 shares traded.
Over the past week, the price has changed by -1.89%, over one month by +0.34%, over three months by +2.41% and over the past year by -49.43%.
Probably not. Based on ValueRay Fundamental Analyses, National Vision Holdings (NASDAQ:EYE) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.03 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EYE as of March 2025 is 9.72. This means that EYE is currently overvalued and has a potential downside of -18.39%.
National Vision Holdings has received a consensus analysts rating of 3.64. Therefor, it is recommend to hold EYE.
- Strong Buy: 4
- Buy: 0
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, EYE National Vision Holdings will be worth about 10.6 in March 2026. The stock is currently trading at 11.91. This means that the stock has a potential downside of -10.66%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14.4 | 20.5% |
Analysts Target Price | 13.6 | 14.2% |
ValueRay Target Price | 10.6 | -10.7% |